CureVac is a pioneering biotech company focused on mRNA drugs for oncology and vaccines. In biotech, value derives from research quality, patent strength, and clinical success probability, not current ...

GSK plc names new CEO as shares rise 3% and maintains a 4% dividend yield; get key insights on GSK stock's outlook and what to expect from leadership changes.

GSK Chief Executive Emma Walmsley, the first woman to lead a major pharmaceutical company, will step down Dec. 31 after more than eight years at the head of the London-based drugmaker ...

The shares of GlaxoSmithKline ($GSK) cheered on Monday after the British pharmaceutical giant announced that its chief executive, Emma Walmsley, ...

GSK chief executive Emma Walmsley is to step down after more than eight years running the pharmaceuticals giant.

GSK plc (NYSE: GSK) appointed Luke Miels as the CEO Designate of GSK. He will assume full responsibility as CEO and join the Board on January 1, 2026. Luke will succeed the current CEO, Dame Emma ...

Electronic Arts Inc (NASDAQ:EA) has agreed to be acquired in a $55 billion all-cash transaction led by Saudi Arabia’s Public Investment Fund, Silver Lake and Affinity Partners, marking what would be ...

Dame Emma Walmsley will step down as GSK’s chief executive at the end of the year, concluding nine years at the helm of Britain’s second-largest pharmaceuticals company.

London's stock market saw gains on Monday, led by a rise in healthcare shares. The FTSE 100 and FTSE 250 both climbed 0.6% while investors also focused on the possibility of a U.S. government shutdown ...

Pharmaceuticals firm GSK has announced a shock change at the very top, with CEO Dame Emma Walmsley opting to step down after eight years in charge. At such a critical moment in US history, we need ...

Stock futures were higher Monday morning while Treasury yields slipped as investors awaited September’s upcoming nonfarm payrolls report, hoping for clarity on U.S. labor market health, while also ...

One factor threatening to push inflation higher, adding to consumer woes, is President Donald Trump’s tariffs, and he announced more late Thursday. They include taxes on imports of some pharmaceutical ...